Study finds hepatitis C treatment could be cut in half in 50 percent of patients

Hepatitis C drugs cure more than 90 percent of patients, but can cost more than $50,000 per patient. Findings from a new study could lead to significant cost savings. Preliminary data from the study, co-led by a theoretical modeling researcher from Loyola University Chicago Stritch School of Medicine and Loyola Medicine, found that in 50 ["]

The post Study finds hepatitis C treatment could be cut in half in 50 percent of patients appeared first on Outbreak News Today.